Miles Piper

598 total citations
14 papers, 191 citations indexed

About

Miles Piper is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Miles Piper has authored 14 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Miles Piper's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Miles Piper is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Miles Piper collaborates with scholars based in United States, Canada and Switzerland. Miles Piper's co-authors include Sana D. Karam, Adam C. Mueller, Thomas E. Bickett, Benjamin Van Court, Michael W. Knitz, Shilpa Bhatia, Siwen Hu‐Lieskovan, Jacob Gadwa, Eytan Ruppin and Laurel B. Darragh and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Miles Piper

12 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miles Piper United States	9	104	99	57	30	19	14	191
Jacob Gadwa United States	7	108 1.0×	88 0.9×	45 0.8×	19 0.6×	37 1.9×	14	196
Michael W. Knitz United States	7	111 1.1×	86 0.9×	39 0.7×	19 0.6×	36 1.9×	14	193
Diemmy Nguyen United States	7	98 0.9×	78 0.8×	37 0.6×	18 0.6×	34 1.8×	13	181
Maximilian M. L. Knott Germany	7	133 1.3×	138 1.4×	104 1.8×	35 1.2×	49 2.6×	11	276
Hongyan Huang China	6	130 1.3×	120 1.2×	122 2.1×	39 1.3×	25 1.3×	8	271
Ruoyang Shao China	6	53 0.5×	77 0.8×	96 1.7×	27 0.9×	14 0.7×	13	206
Isaias Hernández-Verdín France	6	103 1.0×	95 1.0×	38 0.7×	16 0.5×	19 1.0×	14	186
Dasa He China	5	89 0.9×	59 0.6×	92 1.6×	47 1.6×	30 1.6×	7	194
John Weightman United Kingdom	5	215 2.1×	161 1.6×	63 1.1×	45 1.5×	29 1.5×	6	282
Can Di China	5	149 1.4×	155 1.6×	89 1.6×	57 1.9×	35 1.8×	7	286

Countries citing papers authored by Miles Piper

Since Specialization

Citations

This map shows the geographic impact of Miles Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles Piper more than expected).

Fields of papers citing papers by Miles Piper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles Piper. The network helps show where Miles Piper may publish in the future.

Co-authorship network of co-authors of Miles Piper

This figure shows the co-authorship network connecting the top 25 collaborators of Miles Piper. A scholar is included among the top collaborators of Miles Piper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles Piper. Miles Piper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gadwa, Jacob, Justin Yu, Miles Piper, et al.. (2025). Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e010405–e010405. 1 indexed citations

Amo‐Aparicio, Jesús, Shaikh M. Atif, Alberto Dinarello, et al.. (2023). Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment. Cancer Research Communications. 3(9). 1899–1911. 8 indexed citations

Gadwa, Jacob, Maria Amann, Thomas E. Bickett, et al.. (2023). Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC. Cell Reports Medicine. 4(8). 101150–101150. 14 indexed citations

Piper, Miles, Richard B. Ross, Junxiao Hu, et al.. (2023). Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 116(3). 627–639. 4 indexed citations

Piper, Miles, Harriet M. Kluger, Eytan Ruppin, & Siwen Hu‐Lieskovan. (2023). Immune Resistance Mechanisms and the Road to Personalized Immunotherapy. American Society of Clinical Oncology Educational Book. 43(43). e390290–e390290. 23 indexed citations

Knitz, Michael W., Thomas E. Bickett, Laurel B. Darragh, et al.. (2022). Sexual dimorphism and the effect of therapeutic low-dose estrogen in head and neck squamous cell carcinoma. The Journal of Immunology. 208(Supplement_1). 63.10–63.10.

Bickett, Thomas E., Michael W. Knitz, Laurel B. Darragh, et al.. (2021). FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC. Clinical Cancer Research. 27(22). 6235–6249. 22 indexed citations

Bickett, Thomas E., Michael W. Knitz, Miles Piper, et al.. (2021). Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC. Molecular Therapy. 30(3). 1149–1162. 6 indexed citations

Knitz, Michael W., Laurel B. Darragh, Thomas E. Bickett, et al.. (2021). Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma. Cancer Immunology Immunotherapy. 71(5). 1049–1061. 8 indexed citations

10.

Gadwa, Jacob, Thomas E. Bickett, Laurel B. Darragh, et al.. (2021). Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer. Journal for ImmunoTherapy of Cancer. 9(3). e002585–e002585. 25 indexed citations

11.

Piper, Miles, Benjamin Van Court, Anja Müeller, et al.. (2021). P-218 STAT3 signaling inhibition in regulatory T cells improves immune response to RT in PDAC. Annals of Oncology. 32. S173–S173.

12.

Oweida, Ayman, Adam C. Mueller, Miles Piper, et al.. (2020). Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology Immunotherapy. 70(4). 989–1000. 27 indexed citations

13.

Bhatia, Shilpa, Sanjana Bukkapatnam, Benjamin Van Court, et al.. (2020). The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Molecular Carcinogenesis. 59(9). 1064–1075. 13 indexed citations

14.

Piper, Miles, Adam C. Mueller, & Sana D. Karam. (2020). The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy. Molecular Carcinogenesis. 59(7). 754–765. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact